Paper40650397
The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies.
Tonin G and 6 others. Obes Rev, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies. Papers, record 40650397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40650397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Obesity | Major topic |
| Humans | |
| Anti-Obesity Agents |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P4-0220 | Slovenian Research and Innovation Agency (ARIS) | PubMed | ||
| J7-60131 | Slovenian Research and Innovation Agency (ARIS) | PubMed |
Source PubMed
References406
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26833246 | New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. | Nat Commun | 2016 | https://conductscience.org/library/papers/26833246 | PubMed |
| 2 | 37840095 | Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial. | Nat Med | 2023 | https://conductscience.org/library/papers/37840095 | PubMed |
| 3 | 12917707 | Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene. | Int J Obes Relat Metab Disord | 2003 | https://conductscience.org/library/papers/12917707 | PubMed |
| 4 | 37758044 | Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics. | Am Heart J | 2024 | https://conductscience.org/library/papers/37758044 | PubMed |
| 5 | 37993268 | Genetic variant rs9939609 in FTO is associated with body composition and obesity risk in Korean females. | BMJ Open Diabetes Res Care | 2023 | https://conductscience.org/library/papers/37993268 | PubMed |
| 6 | 28951828 | The glucoregulatory actions of leptin. | Mol Metab | 2017 | https://conductscience.org/library/papers/28951828 | PubMed |
| 7 | 30937899 | Associations of the melanocortin 3 receptor C17A + G241A haplotype with body composition and inflammation in African-American adults. | Ann Hum Genet | 2019 | https://conductscience.org/library/papers/30937899 | PubMed |
| 8 | 37524416 | Future therapies for obesity. | Clin Med (Lond) | 2023 | https://conductscience.org/library/papers/37524416 | PubMed |
| 9 | 31918705 | Cocaine and amphetamine-regulated transcript prepropeptide gene (CARTPT) polymorphism interacts with Diet Quality Index-International (DQI-I) and Healthy Eating Index (HEI) to affect hypothalamic hormones and cardio-metabolic risk factors among obese individuals. | J Transl Med | 2020 | https://conductscience.org/library/papers/31918705 | PubMed |
| 10 | 33137293 | Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. | Lancet Diabetes Endocrinol | 2020 | https://conductscience.org/library/papers/33137293 | PubMed |
| 11 | 28363697 | Polymorphisms and mutations in the melanocortin-3 receptor and their relation to human obesity. | Biochim Biophys Acta Mol Basis Dis | 2017 | https://conductscience.org/library/papers/28363697 | PubMed |
| 12 | 29031731 | Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency. | Mol Metab | 2017 | https://conductscience.org/library/papers/29031731 | PubMed |
| 13 | 33086065 | The Obesity-Susceptibility Gene TMEM18 Promotes Adipogenesis through Activation of PPARG. | Cell Rep | 2020 | https://conductscience.org/library/papers/33086065 | PubMed |
| 14 | 37385275 | Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. | Lancet | 2023 | https://conductscience.org/library/papers/37385275 | PubMed |
| 15 | 30104138 | The FTO rs9939609 polymorphism and obesity risk in teens: Evidence-based meta-analysis. | Obes Res Clin Pract | 2018 | https://conductscience.org/library/papers/30104138 | PubMed |
| 16 | 8548812 | Identification and expression cloning of a leptin receptor, OB-R. | Cell | 1995 | https://conductscience.org/library/papers/8548812 | PubMed |
| 17 | 26808323 | Complications of bariatric surgery: Presentation and emergency management. | Int J Surg | 2016 | https://conductscience.org/library/papers/26808323 | PubMed |
| 18 | 10730683 | Orlistat, a new lipase inhibitor for the management of obesity. | Pharmacotherapy | 2000 | https://conductscience.org/library/papers/10730683 | PubMed |
| 19 | 31000663 | Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq. | Science | 2019 | https://conductscience.org/library/papers/31000663 | PubMed |
| 20 | 27241181 | Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016. | Obes Facts | 2016 | https://conductscience.org/library/papers/27241181 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941593 | Obesity in the 21st Century: Where Do We Stand? | J Clin Med | 2026 | https://conductscience.org/library/papers/42941593 | PubMed |
| 42415904 | The potential effect of whey protein supplementation in post-bariatric surgery patients: a systematic review and meta-analysis of randomized controlled trials. | Front Nutr | 2026 | https://conductscience.org/library/papers/42415904 | PubMed |
| 42375965 | Physiological interplay among obesity, male fertility, and aryl hydrocarbon receptor in human and mice: A mini review. | Open Vet J | 2026 | https://conductscience.org/library/papers/42375965 | PubMed |
| 42244943 | Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42244943 | PubMed |
| 41788781 | The role of PYY in improving insulin resistance. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41788781 | PubMed |
| 41445541 | Advances in Microneedle Drug Delivery for Obesity: Mechanisms, Applications, and Perspectives. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41445541 | PubMed |
| 41226372 | Impact of Bariatric Surgery on the Expression of Fertility-Related Genes in Obese Women: A Systematic Review of LEP, LEPR, MC4R, FTO, and POMC. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41226372 | PubMed |
| 40650397 | The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies. | Obes Rev | 2025 | https://conductscience.org/library/papers/40650397 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PYY | 5697 | PubTator's text mining | https://conductscience.org/library/genes/5697 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40650397
GET https://conductscience.org/api/papers/v1/40650397/references?page=2